Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

BI 836909, a Novel Bispecific T Cell Engager for the Treatment of Multiple Myeloma Induces Highly Specific and Efficacious Lysis of Multiple Myeloma Cells in Vitro and Shows Anti-Tumor Activity in Vivo

Susanne Hipp, PhD, Petra Deegen, Joachim Wahl, PhD, Diann Blanset, PhD, Oliver Thomas, Benno Rattel, PhD, Paul Adam, PhD, Matthias Friedrich, PhD

Blood (2015) 126 (23): 2999.

https://doi.org/10.1182/blood.V126.23.2999.2999

Published: 2015

Journal Articles

MTOR (Mammalian Target of Rapamycin) Inhibition with RAD001 Induces Cell Cycle Arrest in Diffuse Large B Cell Lymphoma (DLBCL) Cells and Sensitizes DLBCL Cells to Rituximab Therapy.

Kathrin Wanner, Susanne Hipp, Christian Peschel, MD, Thomas Decker, MD

Blood (2004) 104 (11): 4620.

https://doi.org/10.1182/blood.V104.11.4620.4620

Published: 2004

Journal Articles

Rapamycin-induced G 1 arrest in cycling B-CLL cells is associated with reduced expression of cyclin D3, cyclin E, cyclin A, and survivin

Thomas Decker, Susanne Hipp, Ingo Ringshausen, Christian Bogner, Madlene Oelsner, Folker Schneller, Christian Peschel

Blood (2003) 101 (1): 278–285.

https://doi.org/10.1182/blood-2002-01-0189

Published: 2003

Journal Articles

Constitutively activated phosphatidylinositol-3 kinase (PI-3K) is involved in the defect of apoptosis in B-CLL: association with protein kinase Cδ

Ingo Ringshausen, Folker Schneller, Christian Bogner, Susanne Hipp, Justus Duyster, Christian Peschel, Thomas Decker

Blood (2002) 100 (10): 3741–3748.

https://doi.org/10.1182/blood-2002-02-0539

Published: 2002

Journal Articles

Sensitization of B-cell chronic lymphocytic leukemia cells to recombinant immunotoxin by immunostimulatory phosphorothioate oligodeoxynucleotides

Thomas Decker, Susanne Hipp, Robert J. Kreitman, Ira Pastan, Christian Peschel, Thomas Licht

Blood (2002) 99 (4): 1320–1326.

https://doi.org/10.1182/blood.V99.4.1320.h8001320_1320_1326

Published: 2002

NARROW

BI 836909, a Novel Bispecific T Cell Engager for the Treatment of Multiple Myeloma Induces Highly Specific and Efficacious Lysis of Multiple Myeloma Cells in Vitro and Shows Anti-Tumor Activity in Vivo

MTOR (Mammalian Target of Rapamycin) Inhibition with RAD001 Induces Cell Cycle Arrest in Diffuse Large B Cell Lymphoma (DLBCL) Cells and Sensitizes DLBCL Cells to Rituximab Therapy.

Rapamycin-induced G 1 arrest in cycling B-CLL cells is associated with reduced expression of cyclin D3, cyclin E, cyclin A, and survivin

Constitutively activated phosphatidylinositol-3 kinase (PI-3K) is involved in the defect of apoptosis in B-CLL: association with protein kinase Cδ

Sensitization of B-cell chronic lymphocytic leukemia cells to recombinant immunotoxin by immunostimulatory phosphorothioate oligodeoxynucleotides

Email alerts

ASH Publications

American Society of Hematology

BI 836909, a Novel Bispecific T Cell Engager for the Treatment of Multiple Myeloma Induces Highly Specific and Efficacious Lysis of Multiple Myeloma Cells in Vitro and Shows Anti-Tumor Activity in Vivo

MTOR (Mammalian Target of Rapamycin) Inhibition with RAD001 Induces Cell Cycle Arrest in Diffuse Large B Cell Lymphoma (DLBCL) Cells and Sensitizes DLBCL Cells to Rituximab Therapy.

Rapamycin-induced G 1 arrest in cycling B-CLL cells is associated with reduced expression of cyclin D3, cyclin E, cyclin A, and survivin

Constitutively activated phosphatidylinositol-3 kinase (PI-3K) is involved in the defect of apoptosis in B-CLL: association with protein kinase Cδ

Sensitization of B-cell chronic lymphocytic leukemia cells to recombinant immunotoxin by immunostimulatory phosphorothioate oligodeoxynucleotides

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only